Brief: Forward Pharma receives $1.25 bln pursuant to settlement and license agreement with Biogen

Forward Pharma A/S

09/02/2017 13:30

Feb 9 (Reuters) - Forward Pharma A/S  FWP.O  -  
    * Forward Pharma received US$ 1.25 bln pursuant to 
settlement and license agreement with Biogen 
    * Forward Pharma A/S - received non-refundable cash fee of 
US$1.25 billion in connection with settlement and license 
agreement with two units of Biogen 
 
Source text for Eikon:  ID:nGNXNQBUBa  
Further company coverage:  FWP.O  
 
 ((Bangalore.newsroom@thomsonreuters.com))